在冠状动脉微血管疾病患者中循环生物标志物的作用
Rossella Quarta1,2, Giovanni Martino3, Letizia Rosa Romano2,3
1Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.
Biomolecules
|February 26, 2025
概括
冠状动脉微血管疾病 (CMD) 的诊断是具有挑战性的. 本综述探讨了通过血液检测检测到的循环生物标志物,以帮助诊断CMD并指导患者护理.
科学领域:
- 心脏病学 心脏病学
- 生物标志物研究 生物标志物研究
- 诊断成像 诊断成像 诊断成像
背景情况:
- 冠状动脉微血管疾病 (CMD) 涉及小冠状动脉血管 (<500微米) 的异常,导致心肌缺血.
- 由于当前诊断方法的局限性,包括侵入性测试和非侵入性技术的可变准确性,CMD往往被诊断不足.
- 循环生物标志物正在成为CMD评估的潜在辅助物.
研究的目的:
- 审查在侵袭性证实CMD的患者中循环生物标志物的研究.
- 探索生物标志物的作用,以了解CMD的病原性.
- 提高诊断准确度和CMD的临床管理.
主要方法:
- 对评估CMD患者生物标志物的研究进行叙述性审查.
- 专注于与侵入性冠状动脉微循环评估相关的生物标志物.
- 分析与内皮功能障碍,炎症和氧化应激相关的生物标志物.
主要成果:
- 循环生物标志物可以提供关于CMD的见解.
- 生物标志物可能有助于早期查和风险分层.
- 生物标志物在监测治疗反应中的潜力.
结论:
- 循环生物标志物显示出改善CMD诊断和管理的前景.
- 对生物标志物的进一步研究可以加强非侵入性查和患者分层.
- 生物标志物辅助评估可以补充侵入性诊断的黄金标准.
更多相关视频
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
8.1K
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
3.4K
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
80
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
80
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
41
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
41